General
Preferred name
MOSAPRIDE
Synonyms
Mosapride Citrate ()
TAK-370 citrate ()
AS-4370 citrate ()
TAK-370 ()
AS-4370 ()
Mosapride (citrate dihydrate) ()
Mosapride (citrate) ()
TAK-370 (citrate dihydrate) ()
AS-4370 (citrate dihydrate) ()
TAK-370, AS-4370, Gasmotin ()
Gasmotin ()
Rimopride citrate ()
Mosart ()
Mosaprida ()
P&D ID
PD013592
CAS
112885-42-4
112885-41-3
636582-62-2
Tags
available
drug
drug candidate
First approval
1998
Drug Status
approved
investigational
Max Phase
3.0
Drug indication
Irritable bowel syndrome
Dyspepsia
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Mosapride citrate is an orally active gastroenterokinetic compound. Mosapride citrate is a 5HT4 agonist. Mosapride citrate is a CYP inducer. Mosapride citrate has a concentration-dependent inhibitory effect on Kv4.3, and its IC50 value is 15.2 ¦ÌM. Mosapride citrate can be used in the study of gastrointestinal diseases[1][2][3][4][5][6][7].
PRICE 40
DESCRIPTION Marketed formulations contain mosapride citrate (PubChem CID 119583). (GtoPdb)
DESCRIPTION Mosapride is an orally active gastroenterokinetic compound. Mosapride is a 5HT4 agonist. Mosapride is a CYP inducer. Mosapride has a concentration-dependent inhibitory effect on Kv4.3, and its IC50 value is 15.2 ¦ÌM. Mosapride can be used in the study of gastrointestinal diseases[1][2][3][4][5][6][7].
PRICE 36
DESCRIPTION Muscarinic receptor antagonist; some selectivity for M1 (Tocris Bioactive Compound Library)
DESCRIPTION 5-HT4 agonist and 5-HT3 antagonist (Tocriscreen Plus)
DESCRIPTION Mosapride Citrate (TAK-370 citrate), a gastroprokinetic agent, utilizes as a selective 5HT4 agonist. (TargetMol Bioactive Compound Library)
DESCRIPTION Mosapride (AS-4370) is a selective 5HT4 agonist (TargetMol Bioactive Compound Library)
Compound Sets
22
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMatrix
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
Ki Database
LSP-MoA library (Laboratory of Systems Pharmacology)
Mcule NIBR MoA Box Subset
MedChem Express Bioactive Compound Library
NIH Clinical Collections (NCC)
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
Tocriscreen Plus
External IDs
109
Properties
(calculated by RDKit )
Molecular Weight
421.16
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
7
Ring Count
3
Aromatic Ring Count
2
cLogP
3.09
TPSA
76.82
Fraction CSP3
0.38
Chiral centers
1.0
Largest ring
6.0
QED
0.67
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
7-TM Receptors
Target
5-HT Receptor
5-HT4
5-HT
Cytochrome P450
Potassium Channel
Primary Target
5-HT4 Receptors
MOA
5-HT Receptor agonist
Agonist
5-HT4 Agonists
Member status
member
Pathway
GPCR/G protein
Membrane Transporter/Ion Channel
Metabolic Enzyme/Protease
Neuronal Signaling
Neuroscience
Source data